Amicus Therapeutics, Inc. Profile Avatar - Palmy Investing

Amicus Therapeutics, Inc.

Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults wit…

Biotechnology
US, Philadelphia [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Amicus Therapeutics, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
0.0 IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
YoY Trends
  • No trends presentable at the moment.

Spending By Type

Awards
Obligations
Contracts IDV Contracts Grants Loans Direct Other

Amicus Therapeutics, Inc. can't present spending by time.

End of FOLD's Analysis
CIK: 1178879 CUSIP: 03152W109 ISIN: US03152W1099 LEI: - UEI: -
Secondary Listings
FOLD has no secondary listings inside our databases.